Literature DB >> 1505291

Low bone mineral density in patients with inflammatory bowel disease.

F Pigot1, C Roux, S Chaussade, D Hardelin, O Pelleter, T Du Puy Montbrun, V Listrat, M Dougados, D Couturier, B Amor.   

Abstract

To assess the prevalence and risk factors for low bone mineral density in inflammatory bowel disease, we studied 61 consecutive patients, mean age 36 +/- 11 years. Twenty-seven had a Crohn's disease and 34 ulcerative colitis (including 13 with ileoanal anastomosis). Three patients, two women and one man (32, 70, and 45 years old, respectively) had vertebral crush fractures. Bone mineral density measured by dual energy x-ray absorptiometry at spine and femoral level was more than 2 SD below normal values in 23% of the patients, all of them having received steroid therapy. Eighteen patients (29%) had never received steroid therapy; their bone mineral density was not different than those who had. Univariate analysis showed a positive correlation between bone mineral density and body weight or oral calcium intakes, and a negative correlation with steroid daily dose. After ileoanal anastomosis, bone mineral density was not different from other groups and showed a positive correlation with time elapsed since coloproctectomy. We concluded that bone mineral density is low in patients with inflammatory bowel disease and exposes them to the risk of bone fracture. Bone mineral density after ileoanal anastomosis may increase with time after surgery.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505291     DOI: 10.1007/bf01296010

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Corticosteroid effects on proximal femur bone loss.

Authors:  P Sambrook; J Birmingham; S Kempler; P Kelly; S Eberl; N Pocock; M Yeates; J Eisman
Journal:  J Bone Miner Res       Date:  1990-12       Impact factor: 6.741

2.  Influence of the menopause and aging on spinal density in French women.

Authors:  C Ribot; F Tremollieres; J M Pouilles; J P Louvet; R Guiraud
Journal:  Bone Miner       Date:  1988-10

3.  Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease.

Authors:  R J Motley; E O Crawley; C Evans; J Rhodes; J E Compston
Journal:  Gut       Date:  1988-10       Impact factor: 23.059

Review 4.  Glucocorticoid-induced osteoporosis: pathogenesis and management.

Authors:  B P Lukert; L G Raisz
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

5.  Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; D M Black; M C Nevitt; W S Browner; J A Cauley; H K Genant; S R Mascioli; J C Scott; D G Seeley; P Steiger
Journal:  JAMA       Date:  1990-02-02       Impact factor: 56.272

6.  Nutritional assessment: a comparison of clinical judgement and objective measurements.

Authors:  J P Baker; A S Detsky; D E Wesson; S L Wolman; S Stewart; J Whitewell; B Langer; K N Jeejeebhoy
Journal:  N Engl J Med       Date:  1982-04-22       Impact factor: 91.245

7.  Home nocturnal supplemental nasogastric feedings in growth-retarded adolescents with Crohn's disease.

Authors:  H Aiges; J Markowitz; J Rosa; F Daum
Journal:  Gastroenterology       Date:  1989-10       Impact factor: 22.682

8.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

9.  [Proposal of a system of criteria for the diagnosis of cryptogenetic inflammatory enterocolitis (Crohn's disease and hemorrhagic rectocolitis). A cooperative study by the Cryptogenic Enterocolitis Study Group].

Authors:  P Bernades; P Hecketsweiler; M Benozio; L Descos; Y Geffroy; J Hemet; J Loygue; R Modigliani; F Potet; J P Weill
Journal:  Gastroenterol Clin Biol       Date:  1978-12

10.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

View more
  34 in total

1.  Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study.

Authors:  J Jahnsen; J A Falch; E Aadland; P Mowinckel
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Longitudinal study of bone mineral density in patients with Crohn's disease.

Authors:  D J de Jong; L Mannaerts; L G M van Rossum; F H M Corstens; A H J Naber
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

3.  Ileum resection is the most predictive factor for osteoporosis in patients with Crohn's disease.

Authors:  R A van Hogezand; D Bänffer; A H Zwinderman; E V McCloskey; G Griffioen; N A T Hamdy
Journal:  Osteoporos Int       Date:  2006-01-04       Impact factor: 4.507

4.  Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease.

Authors:  Sarah A Bartram; Robert T Peaston; David J Rawlings; David Walshaw; Roger M Francis; Nick P Thompson
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

5.  Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.

Authors:  C M Bastos; I M Araújo; M H Nogueira-Barbosa; C E G Salmon; F J A de Paula; L E A Troncon
Journal:  Osteoporos Int       Date:  2017-04-12       Impact factor: 4.507

Review 6.  Extraintestinal manifestations and complications in IBD.

Authors:  Claudia Ott; Jürgen Schölmerich
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

7.  The prevalence and risk factors of decreased bone mineral density in firstly diagnosed ulcerative colitis patients in the eastern region of Turkey.

Authors:  Levent Ediz; Ahmet Cumhur Dülger; Murat Toprak; Mehmet Fethi Ceylan; Ozgür Kemik
Journal:  Int J Clin Exp Med       Date:  2011-04-03

8.  Increased degradation of type I collagen in patients with inflammatory bowel disease.

Authors:  J Silvennoinen; L Risteli; T Karttunen; J Risteli
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

9.  Osteoporosis and determinants of bone density in patients with Crohn's disease.

Authors:  R J Robinson; F al-Azzawi; S J Iqbal; T Kryswcki; L Almond; K Abrams; J F Mayberry
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

10.  Effect of exclusive enteral nutrition on bone turnover in children with Crohn's disease.

Authors:  Kylie E Whitten; Steven T Leach; Timothy D Bohane; Helen J Woodhead; Andrew S Day
Journal:  J Gastroenterol       Date:  2009-12-03       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.